Cargando…
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy
Inactivation of p53 found in more than half of human cancers is often associated with increased tumor resistance to anti-cancer therapy. We have previously shown that overexpression of the phosphatase Wip1 in p53-negative tumors sensitizes them to chemotherapeutic agents, while protecting normal tis...
Autores principales: | Clausse, V, Goloudina, A R, Uyanik, B, Kochetkova, E Y, Richaud, S, Fedorova, O A, Hammann, A, Bardou, M, Barlev, N A, Garrido, C, Demidov, O N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855675/ https://www.ncbi.nlm.nih.gov/pubmed/27077811 http://dx.doi.org/10.1038/cddis.2016.96 |
Ejemplares similares
-
Wip1 phosphatase: between p53 and MAPK kinases pathways
por: Goloudina, Anastasia R., et al.
Publicado: (2016) -
DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation
por: Uyanik, B, et al.
Publicado: (2017) -
Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase
por: Shreeram, Sathyavageeswaran, et al.
Publicado: (2006) -
miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress
por: Lezina, L, et al.
Publicado: (2013) -
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
por: Castellino, Robert C., et al.
Publicado: (2007)